| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $71.2M | +45.6% |
| SG&A Expense | $26.3M | +18.3% |
| Operating Income | -$72.6M | -18.1% |
| Interest Expense | $80K | -54.5% |
| Pre-tax Income | -$69.8M | -12.3% |
| Income Tax | $0 | +100.0% |
| Net Income | -$69.8M | -12.6% |
| EPS (Basic) | -$1.70 | +15.0% |
| EPS (Diluted) | -$1.70 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $257.7M | -7.2% |
| Current Assets | $261.0M | -7.6% |
| Total Assets | $330.7M | -2.4% |
| Current Liabilities | $19.7M | +20.8% |
| Total Liabilities | $38.4M | +7.1% |
| Stockholders' Equity | $292.3M | -3.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.8M | +12.3% |
| Capital Expenditures | $16.8M | +28.6% |
| Investing Cash Flow | -$16.8M | -500.2% |
| Financing Cash Flow | $41.5M | -82.9% |
| Free Cash Flow | -$61.5M | +4.0% |
| +15.0% |